- Home
- FSM vs NRIX Comparison
FSM vs NRIX Comparison
Compare FSM & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSM | NRIX |
|---|---|---|
| Founded | 1990 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FSM | NRIX |
|---|---|---|
| Price | $8.45 | $23.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | $14.00 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 4.5M | 1.9M |
| Earning Date | 05-06-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $76,987,000.00 |
| Revenue This Year | $38.01 | N/A |
| Revenue Next Year | N/A | $48.05 |
| P/E Ratio | $14.10 | ★ N/A |
| Revenue Growth | N/A | ★ 99.31 |
| 52 Week Low | $6.17 | $8.20 |
| 52 Week High | $13.85 | $25.09 |
Technical Indicators
Market Signals| Indicator | FSM | NRIX |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 62.87 |
| Support Level | $8.39 | $14.63 |
| Resistance Level | $8.88 | $24.98 |
| Average True Range (ATR) | 0.31 | 1.22 |
| MACD | 0.02 | -0.27 |
| Stochastic Oscillator | 50.20 | 62.00 |
Price Performance
Historical ComparisonAbout FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'voire, Mexico, and Peru. The company's segment consists of Mansfield, Sango, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d' Ivoire location.
About NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.